PRELIMINARY PHASE II TRIALS WITH 1-AMINOCYCLOPENTANE CARBOXYLIC ACID (NSC-1026).
D000970:Antineoplastic Agents; D001774:Blood Chemical Analysis; D002264:Carboxylic Acids; D003515:Cycloleucine; D003516:Cycloparaffins; D004906:Erythrocyte Count; D005853:Geriatrics; D007267:Injections; D007275:Injections, Intravenous; D007958:Leukocyte Count; D011506:Proteins / Q000378:metabolism*; D014116:Toxicology; D014556:Urine; D014633:Valine
D000970:Antineoplastic Agents; D002264:Carboxylic Acids; D003516:Cycloparaffins; D011506:Proteins; D003515:Cycloleucine; D014633:Valine
ANTINEOPLASTIC AGENTS; BLOOD CHEMICAL ANALYSIS; CYCLOPARAFFINS; ERYTHROCYTE COUNT; GERIATRICS; INJECTIONS, INTRAVENOUS; LEUKOCYTE COUNT; PROTEIN METABOLISM; TOXICOLOGIC REPORT; URINE; VALINE